Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques by C. R. Pfaltz, Robert B. McCall, Ray W. Fuller, Richard M. Schultz, David A. Solomon, Edison Miyawaki, Carl Salzman, Philip J. Podrid, Lisa Mendes, Scott L. Beau, John S. Wilson, Donald T. Witiak, Youg Wei, Satyavan Sharma, Alberto Mantovani, Annunciata Vecchi, Pushkar N. Kaul ; edited by Ernst Jucker.

Сохранить в:
Библиографические подробности
Главные авторы: Pfaltz, C. R. (Автор), McCall, Robert B. (Автор), Fuller, Ray W. (Автор), Schultz, Richard M. (Автор), Solomon, David A. (Автор), Miyawaki, Edison (Автор), Salzman, Carl (Автор), Podrid, Philip J. (Автор), Mendes, Lisa (Автор), Beau, Scott L. (Автор), Wilson, John S. (Автор), Witiak, Donald T. (Автор), Wei, Youg (Автор), Sharma, Satyavan (Автор), Mantovani, Alberto (Автор), Vecchi, Annunciata (Автор), Kaul, Pushkar N. (Автор)
Соавтор: SpringerLink (Online service)
Другие авторы: Jucker, Ernst (Редактор)
Формат: eКнига
Язык:English
Опубликовано: Basel : Birkhäuser Basel : Imprint: Birkhäuser, 1990.
Серии:Progress in Drug Research, Tagungsberichte ; 35
Springer eBook Collection.
Предметы:
Online-ссылка:http://dx.doi.org/10.1007/978-3-0348-7133-4
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Описание
Итог:Volume 36 of "Progress in Drug Research" contains 5 articles and the various indexes which facilitate its use and establish the connec­ tion with the previous volumes. While all articles deal with some of the topical aspects of drug research, the contribution by Robert R. Ruffolo et al. on "Drug receptors and control of the cardiovas­ cular system: Recent advances" is indeed in its own right a mono­ graphic presentation of this important domain. The remaining four reviews provide an overview of the work in­ volved in the search for new and better medicines, with a focus on chemical, pharmacological, toxicological, biological, biochemical and molecular modeling studies. In the 31 years this series has existed, the Editor has enjoyed the help and advice of many colleagues. Readers, the authors of the in­ dividual articles, and, last but not least, the reviewers have all con­ tributed greatly to the success of PDR. Although many comments received have been favorable, it is nevertheless necessary to analyze and to reconsider the current position and the direction of such a series. So far, it has been the Editor's aim to help spread informa­ tion on the vast domain of drug research, and to provide the reader with a tool helping him or her to keep abreast of the latest develop­ ments and trends.
Объем:VIII, 606 p. online resource.
ISBN:9783034871334
DOI:10.1007/978-3-0348-7133-4